Get started
Author

Txomin Arbizu

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
2008 · G Comi, A Pulizzi, et al. · The Lancet · 277
Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease
1997 · F Graus, J Dalmau, et al. · Journal of Neuroimmunology · 208
A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure
1983 · Txomin Arbizu, Joan Santamaría, et al. · Journal of the Neurological Sciences · 172
Paraneoplastic cerebellar degeneration
1992 · P. D. Clouston, C. B. Saper, et al. · Neurology · 147
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial
2016 · Ludwig Kappos, Gilles Edan, et al. · Neurology · 131
PDF
Rhombencephalitis
2011 · Mireia Moragas, Sergio Martínez-Yélamos, et al. · Medicine · 94
MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS
2001 · A. Saiz, E. Carreras, et al. · Neurology · 88
PDF
Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS
2004 · A. Saiz, Y. Blanco, et al. · Neurology · 81
Teriflunomide added to interferon-β in relapsing multiple sclerosis
2012 · M.S. Freedman, J.S. Wolinsky, et al. · Neurology · 80
Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study)
2010 · The Novo Group, O. Fernández, et al. · Journal of Neurology · 70
Cerebral infarction of the basal ganglia due to embolism from the heart.
1983 · J Santamaria, F Graus, et al. · Stroke · 70
PDF
14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis
2001 · A. Martínez–Yélamos, A. Saiz, et al. · Neurology · 66
PDF
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study
2010 · G. Comi, O Abramsky, et al. · Multiple Sclerosis Journal · 62
Effect of glatiramer acetate (Copaxone®) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: A longitudinal study
2006 · Y. Blanco, E.A. Moral, et al. · Neuroscience Letters · 58
Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases
2006 · J Bruna, S Martínez-Yélamos, et al. · Multiple Sclerosis Journal · 58
Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability
2006 · Virginia Casado, Sergio Martínez-Yélamos, et al. · BMC Health Services Research · 49
PDF
Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis
2004 · Antonio Martı́nez-Yélamos, Albert Saiz, et al. · Neuroscience Letters · 48
Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study
2010 · Virginia Devonshire, Txomin Arbizu, et al. · BMC Neurology · 47
PDF
A Golgi and ultrastructural study of a dominant form of Kufs' disease
1980 · I. Ferrer, T. Arbizu, et al. · Journal of Neurology · 43
Specificity of frontal dysfunctions in relapsing–remitting multiple sclerosis
2007 · O SANTIAGO, J GUARDIA, et al. · Archives of Clinical Neuropsychology · 37
HLA‐DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population
2010 · L. Romero‐Pinel, J. M. Pujal, et al. · European Journal of Neurology · 35
Clinical skills assessment with standardized patients
1997 · J M Gómez, L Prieto, et al. · Medical Education · 35
Documento de consenso de la Sociedad Española de Neurología sobre el uso de medicamentos en esclerosis múltiple: escalado terapéutico
2010 · A. García Merino, O. Fernández, et al. · Neurología · 32
Anticipation of age at onset in familial multiple sclerosis
2009 · L. Romero‐Pinel, S. Martínez‐Yélamos, et al. · European Journal of Neurology · 31
An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain
2007 · V. Casado, L. Romero, et al. · Multiple Sclerosis Journal · 31
Works count: 82
Citation count: 2,595
H-index: 28
I10-index: 47
Year
Topic
Type